Feeds:
Posts
Comments

Archive for the ‘Brachytherapy’ Category

PROSTABLOG NZ: This story and picture in today’s Dominion-Post newspaper shows how poor media coverage is on the topic of prostate cancer.

It suggests that brachytherapy radiation treatment – largely available only at a private clinic in Tauranga for about $30,000 – is now fully available to the public at Wellington Hospital.

Is it? The story doesn’t really explain. What kind of brachytherapy are we talking about here?

Hopefully, someone can enlighten us…

Read Full Post »

URO TODAY: Radiation dose delivered to the prostate and nearby organs in every brachytherapy procedure should be carefully analysed using post-implant CT or MRI and uniformly documented in every patient, according to new brachytherapy guidelines just issued in the US. READ MORE>

Read Full Post »

URO TODAY: Permanent brachytherapy implants sometimes have a detrimental effect on a patient’s bowel, so German researchers have been looking at whether side effects are any worse 30 days to a year after treatment. READ MORE>

Read Full Post »

URO TODAY: Italian researchers have been studying the effectiveness of treating locally advanced prostate cancer with external beam radiation therapy combined with high-dose-rate brachytherapy as a boost. READ MORE>

Read Full Post »

DOMINION POST: Prostate cancer patients are being offered faster, more targeted and more effective treatment with the introduction of a high-dose radiation therapy at Wellington Hospital.

The technique, “high-dose-rate brachytherapy” uses small plastic tubes placed into the prostate and irradiating it from inside.

It will cut radiation treatment from seven to four weeks and is especially effective for advanced cases.

Waikato Hospital is the only other NZ centre to use the technique. READ MORE>

Read Full Post »

NEW PROSTATE CANCER INFOLINK: Either maximal androgen blockade or hormonal monotherapy are reasonable choices for use in combination with brachytherapy in the management of men with intermediate- or high-risk prostate cancer, a retrospective study finds. READ MORE>

[But]…this study is only a retrospective analysis of database information. A prospective, randomised clinical trial (which has never been carried out as far as we are aware) might demonstrate a different outcome.

Read Full Post »

URO TODAY: Forty percent of about 400 men treated with brachytherapy developed urinary obstructive symptoms, generally within the first three to six months, according to a study  of about 400 prostate cancer patients. READ MORE>

These symptoms resolved in a large proportion of men. Impaired potency occurred in 15% of men by six months and in more than 40% of men by 60 months. Bowel symptoms were less common and had a slower onset.

Read Full Post »

« Newer Posts - Older Posts »